Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?

Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?

Abstract Background In absence of contraindication, breast cancer patients of reproductive age can undergo fertility preservation with controlled ovarian stimulation for oocyte/embryo cryopreservation before the administration of potentially gonadotoxic treatments. High hormonal levels induced by ov...

Full description

Bibliographic Details
Main Authors: Imane Lalami, Julie Labrosse, Isabelle Cedrin-Durnerin, Marjorie Comtet, Claire Vinolas, Fabien Krief, Christophe Sifer, Maeliss Peigne, Michael Grynberg
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Reproductive Biology and Endocrinology
Subjects:
Ovarian stimulation
Progesterone
Cryopreservation
Estrogen
Luteal phase
Luteinizing hormone
Online Access:https://doi.org/10.1186/s12958-022-00958-7

Internet

https://doi.org/10.1186/s12958-022-00958-7

Similar Items